2009
DOI: 10.1111/j.1365-2133.2009.09590.x
|View full text |Cite
|
Sign up to set email alerts
|

Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus

Abstract: PPC can be an effective treatment for refractory pemphigus but its adverse effects should be considered prior to therapy and closely monitored in patients on treatment.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
14
0
4

Year Published

2010
2010
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(18 citation statements)
references
References 29 publications
0
14
0
4
Order By: Relevance
“…methylprednisolone 1 g daily over 3 consecutive days with 500 mg of cyclophosphamide has also been used for refractory pemphigus. 14 Early studies describe the administration of cyclophosphamide pulses post-plasmapheresis for severe pemphigus vulgaris (PV) and systemic lupus erythematosus (SLE). [15][16][17] Plasmapheresis acutely reduces pathogenic auto-antibodies through a filtration process administered in cycles; however, it is followed by a rebound burst of antibody production within 2 weeks due to a negative feedback mechanism.…”
Section: Dosage and Administration In Dermatologymentioning
confidence: 99%
“…methylprednisolone 1 g daily over 3 consecutive days with 500 mg of cyclophosphamide has also been used for refractory pemphigus. 14 Early studies describe the administration of cyclophosphamide pulses post-plasmapheresis for severe pemphigus vulgaris (PV) and systemic lupus erythematosus (SLE). [15][16][17] Plasmapheresis acutely reduces pathogenic auto-antibodies through a filtration process administered in cycles; however, it is followed by a rebound burst of antibody production within 2 weeks due to a negative feedback mechanism.…”
Section: Dosage and Administration In Dermatologymentioning
confidence: 99%
“…Steroid pulse therapy is widely used to initiate treatment in patients with rapidly progressive and immunologically mediated disorders such as acute graft rejection, Graves ophthalmopathy, pemphigus, and severe systemic lupus erythematosus [24][25][26][27]. Moreover, high doses of systemic steroid can be given with comparative safety within a period of 1 week [28].…”
Section: Introductionmentioning
confidence: 99%
“…Several case studies have shown rituximab to be efficacious (Hertl et al 2008;Arin et al 2005). Cyclophosphamide is also used in refractory cases, but it has an unsafe side effect profile (Saha et al 2009). It can cause hemorrhagic cystitis.…”
Section: Managementmentioning
confidence: 99%